DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakene (Valproic Acid) - Thrombocytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Thrombocytopenia (29)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Depakene side effects in 75 year old male

Reported by a physician from Japan on 2012-08-07

Patient: 75 year old male

Reactions: Thrombocytopenia, Cerebrovascular Accident

Adverse event resulted in: death

Drug(s) suspected as cause:
Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-15
    End date: 2011-10-20

Lamictal
    Dosage: daily dose: 100 mg
    Administration route: Oral

Depakene
    Dosage: daily dose: 2 g
    Administration route: Oral



Possible Depakene side effects in 75 year old male

Reported by a physician from Japan on 2012-08-07

Patient: 75 year old male

Reactions: Cerebrovascular Accident, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene
    Dosage: daily dose: 2 g
    Administration route: Oral

Lamictal
    Dosage: daily dose: 100 mg
    Administration route: Oral

Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-15
    End date: 2011-10-20



Possible Depakene side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-06

Patient: 50 year old male

Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Eyelid Oedema, Pulmonary Tuberculosis, Encephalitis, Transaminases Increased, Generalised Erythema, Skin Lesion, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Onfi
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-01-01

Depakene
    Dosage: oral
    Administration route: Oral
    Indication: Epilepsy
    End date: 2010-11-30

Lovenox
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-03
    End date: 2011-01-03

Atovaquone
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-01
    End date: 2011-01-01

Bactrim
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-03
    End date: 2011-01-03

Other drugs received by patient: Rifater; Moxifloxacin HCL; Myambutol; Rimifon



Possible Depakene side effects in 50 year old male

Reported by a physician from France on 2012-06-05

Patient: 50 year old male

Reactions: Eyelid Oedema, Bronchopulmonary Aspergillosis, Generalised Erythema, Pulmonary Tuberculosis, Neutropenia, Thrombocytopenia, Transaminases Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clobazam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-01-01

Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-12-30
    End date: 2011-01-03

Atovaquone
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Depakene
    Administration route: Oral
    End date: 2010-11-30

Lovenox
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-03
    End date: 2011-01-03

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-03
    End date: 2011-01-03

Other drugs received by patient: Rimifon; Myambutol; Myambutol; Moxifloxacin



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-25

Patient: male

Reactions: Anaemia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: 1 df
    Administration route: Oral
    Start date: 2011-05-01

Renagel
    Dosage: 1 df
    Administration route: Oral

Aranesp
    Dosage: 0.0667 df

Calciparine
    Start date: 2011-07-08
    End date: 2011-08-08

Citalopram Hydrobromide
    Administration route: Oral

Depakene
    Dosage: 2 df
    Administration route: Oral
    Start date: 2011-07-16

Eupressyl
    Dosage: 3 df
    Administration route: Oral
    Start date: 2011-05-29

Kayexalate
    Dosage: 0.4286 df
    Start date: 2011-06-03

Calcium Carbonate
    Administration route: Oral

Other drugs received by patient: Levetiracetam



Possible Depakene side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-15

Patient: 49 year old female

Reactions: Renal Failure, Vomiting, Drug Ineffective, Pancytopenia, Hypercalcaemia, Somnolence, Thrombocytopenia

Drug(s) suspected as cause:
Depakene
    Dosage: 500 mg, unk
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-09-28
    End date: 2011-10-19

Haldol
    Dosage: 12.5 mg, unk
    Administration route: Oral
    Start date: 2011-10-29
    End date: 2011-10-29

Haldol
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2011-10-30
    End date: 2011-10-30

Haldol
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2011-11-01

Clozapine
    Dosage: 75 mg, unk
    Administration route: Oral
    End date: 2011-11-02

Haldol
    Dosage: 15 mg, unk
    Administration route: Oral
    Start date: 2011-10-20
    End date: 2011-10-28

Haldol
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2011-11-02
    End date: 2011-11-02

Zyprexa
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2011-10-07
    End date: 2011-11-01

Zyprexa
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2011-11-04
    End date: 2011-11-10

Clozapine
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-10-27

Haldol
    Dosage: 7.5 mg, unk
    Administration route: Oral
    Start date: 2011-10-31
    End date: 2011-10-31

Haldol
    Dosage: 7.5 mg, unk
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-10-08
    End date: 2011-10-19

Depakene
    Dosage: 1000 mg, unk
    Administration route: Oral
    Start date: 2011-10-20
    End date: 2011-11-10

Zyprexa
    Dosage: 15 mg, unk
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-09-28
    End date: 2011-10-06

Zyprexa
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2011-11-02
    End date: 2011-11-03

Other drugs received by patient: Diazepam; Cinacalcet Hydrochloride



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-01

Patient: male

Reactions: Abnormal Behaviour, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Dedrogyl; Aspirin; Fenofibrate; Omeprazole



Possible Depakene side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-04-24

Patient: male, weighing 30.0 kg (66.0 pounds)

Reactions: Tablet Physical Issue, Salivary Hypersecretion, Ulcer, Thrombocytopenia, Gastrooesophageal Reflux Disease

Drug(s) suspected as cause:
Depakene

Depakene
    Dosage: 1.5 tablet in the morning, 1.5 tablet at dawn and 1 tablet in the afternoon
    Administration route: Oral
    Indication: Epilepsy

Other drugs received by patient: Lamotrgine; Neuleptil; Nitrazepam



Possible Depakene side effects in male

Reported by a consumer/non-health professional from Brazil on 2012-04-13

Patient: male, weighing 30.0 kg (66.0 pounds)

Reactions: Tablet Physical Issue, Salivary Hypersecretion, Thrombocytopenia, Gastrooesophageal Reflux Disease, Ulcer

Drug(s) suspected as cause:
Depakene
    Dosage: 1.5 tablet in the morning, 1.5 tablet at dawn and 1 tablet in the afternoon
    Administration route: Oral
    Indication: Epilepsy

Depakene

Other drugs received by patient: Neuleptil; Lamotrgine; Nitrazepam



Possible Depakene side effects in 62 year old female

Reported by a physician from France on 2012-04-02

Patient: 62 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Confusional State, Lymphopenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Indication: Affective Disorder

Quetiapine Fumarate
    Administration route: Oral
    Indication: Major Depression
    Start date: 2011-12-29

Other drugs received by patient: Tercian



Possible Depakene side effects in 68 year old female

Reported by a physician from France on 2012-03-21

Patient: 68 year old female

Reactions: Thrombocytopenia

Drug(s) suspected as cause:
Entocort EC
    Administration route: Oral
    Start date: 2011-01-21

Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-01-07

Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-01-07

Other drugs received by patient: Potassium Chloride; Previscan; Hydrocortisone; Pentasa



Possible Depakene side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-20

Patient: 68 year old female

Reactions: Status Epilepticus, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Entocort EC
    Administration route: Oral
    Start date: 2011-01-21

Depakene
    Dosage: total daily dose: 2500 mg
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-01-07

Keppra
    Dosage: total daily dose: 1250 mg
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-01-07

Other drugs received by patient: Pentasa; Potassium Chloride; Previscan; Hydrocortisone



Possible Depakene side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-03

Patient:

Reactions: Renal Impairment, Anaemia, Sepsis, Hydrocephalus, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Eupressyl
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calciparine
    Dosage: 0.2 ml, sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Aranesp
    Dosage: 50 mcg, every 15 days
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: 15 g, 3x/w
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Citalopram Hydrobromide
    Dosage: 20 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Calcium Carbonate
    Dosage: 1 unk, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Renagel
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hyperphosphataemia

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Depakene
    Dosage: 500 mg/kg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-16



Possible Depakene side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01

Patient: 53 year old male

Reactions: Renal Failure, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Calciparine
    Dosage: parenteral injection
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Kayexalate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Depakene
    Dosage: extended release
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-07-16

Renagel
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Aranesp
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Eupressyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calcium Carbonate
    Dosage: daily
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Keppra



Possible Depakene side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-27

Patient: 53 year old male

Reactions: Renal Failure, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate
    Administration route: Oral
    Start date: 2011-06-03

Calcium Carbonate

Aranesp

Calciparine
    Start date: 2011-07-08
    End date: 2011-08-08

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Prednisone TAB
    Start date: 2011-05-01

Renagel
    Administration route: Oral

Citalopram Hydrobromide
    Administration route: Oral

Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-07-16

Other drugs received by patient: Keppra



Possible Depakene side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-27

Patient: 53 year old male

Reactions: Renal Failure, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Calcium Carbonate
    Dosage: daily
    Indication: Product Used FOR Unknown Indication

Renagel
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Depakene
    Dosage: extended release
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-07-16

Aranesp
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Calciparine
    Dosage: parenteral injection
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Citalopram Hydrobromide
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Eupressyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Other drugs received by patient: Keppra



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-23

Patient: male

Reactions: Renal Impairment, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 1 g, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-16

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Renagel
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hyperphosphataemia

Aranesp
    Dosage: 50 mcg, every 15 days
    Indication: Product Used FOR Unknown Indication

Citalopram
    Dosage: 20 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: 15 g, 3x/w
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Eupressyl
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calciparine
    Dosage: 0.2 ml, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Calcium Carbonate
    Dosage: 1 unk, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Depakene side effects in male

Reported by a physician from France on 2011-12-21

Patient: male

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zonegran
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-04-01
    End date: 2008-06-01

Urbanyl
    Dosage: 20 mg
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-06-01
    End date: 2009-01-01

Depakene
    Administration route: Oral
    Indication: Epilepsy
    End date: 2008-06-01

Urbanyl
    Dosage: 30 mg
    Administration route: Oral
    Start date: 2009-01-01

Risperdal Consta
    Indication: Epilepsy
    Start date: 2008-04-01

Depakene
    Administration route: Oral
    Start date: 2008-06-01

Zonegran
    Administration route: Oral
    Start date: 2008-06-01



Possible Depakene side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-21

Patient: 53 year old male

Reactions: Renal Failure, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Renagel
    Administration route: Oral

Aranesp

Calcium Carbonate

Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-07-16

Kayexalate
    Administration route: Oral
    Start date: 2011-06-03

Prednisone TAB
    Start date: 2011-05-01

Calciparine
    Start date: 2011-07-08
    End date: 2011-08-08

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Citalopram
    Administration route: Oral

Other drugs received by patient: Keppra



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-20

Patient: male, weighing 91.7 kg (201.8 pounds)

Reactions: Agitation, Economic Problem, Pruritus, Obsessive-Compulsive Disorder, Conversion Disorder, Dementia, Coma, Acidosis, Oedema Peripheral, Cardiac Failure Congestive, Diabetes Mellitus Inadequate Control, Faecal Incontinence, Abnormal Behaviour, General Physical Health Deterioration, Body Temperature Decreased, Verbal Abuse, Tremor, Alcohol Use, Emotional Distress, Hyperammonaemia, Vitamin D Decreased, Pancreatitis, Sleep Apnoea Syndrome, Atelectasis, Nicotine Dependence, Deafness Bilateral, Adverse Drug Reaction, Ketonuria, Hyperammonaemic Encephalopathy, Pupils Unequal, Cerebellar Atrophy, Anhedonia, Intervertebral Disc Disorder, Anger, Sinusitis, Gastrooesophageal Reflux Disease, Thrombocytopenia, Frontotemporal Dementia, Cataract, N-Acetylglutamate Synthase Deficiency, Cerebral Atrophy, Cognitive Disorder, Intraocular Lens Implant, Blood Lactic Acid Increased, Hyperlipidaemia, Osteoarthritis, Anxiety, Renal Failure, Bipolar Disorder, Hypothyroidism, Physical Disability, Asthenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depakene
    Dosage: unknown dose when started
    Indication: Convulsion Prophylaxis
    Start date: 1982-01-01

Depakene
    Dosage: dose increased to 4000mg/day
    End date: 2006-01-01

Depakene
    Start date: 2007-01-01
    End date: 2010-01-01

Depakene
    Start date: 2006-01-01
    End date: 2007-01-01

Other drugs received by patient: Mysoline; Seroquel; Celexa; Seoquil; Phenobarbital TAB



Possible Depakene side effects in male

Reported by a physician from France on 2011-12-19

Patient: male

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zonegran
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-04-01
    End date: 2008-06-01

Depakene
    Administration route: Oral
    Start date: 2008-06-01

Risperdal Consta
    Indication: Epilepsy
    Start date: 2008-04-01

Depakene
    Administration route: Oral
    Indication: Epilepsy
    End date: 2008-06-01

Urbanyl
    Dosage: 20 mg
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2008-06-01
    End date: 2009-01-01

Urbanyl
    Dosage: 30 mg
    Administration route: Oral
    Start date: 2009-01-01

Zonegran
    Administration route: Oral
    Start date: 2008-06-01



Possible Depakene side effects in male

Reported by a physician from France on 2011-11-15

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Lymphadenopathy, Blood Creatine Phosphokinase Increased, Respiratory Disorder, High Density Lipoprotein Increased, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Dermatitis Bullous, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Cough, Back Pain, Medical Device Complication, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Renal Colic, Corneal Neovascularisation, Skin Exfoliation, Eye Discharge, Scab, Symblepharon, Nephrolithiasis, Photophobia, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Cataract, Epilepsy, Iris Adhesions, Alopecia, Lacrimation Decreased, Gait Disturbance, Asthenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depakene
    Dosage: 1 g daily
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2004-11-23
    End date: 2004-11-23

Trileptal
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2005-02-14
    End date: 2005-02-21

Depakene
    Dosage: 1.5 g daily
    Start date: 2004-11-24
    End date: 2005-02-21

Depakene
    Dosage: 1.6 g daily
    Indication: Partial Seizures
    End date: 2004-11-22

Aspegic 325
    Indication: Influenza Like Illness
    Start date: 2005-02-01

Other drugs received by patient: Levetiracetam; Clobazam; Topiramate; Clonazepam



Possible Depakene side effects in 44 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2011-11-14

Patient: 44 year old male

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lovenox
    Start date: 2011-03-10
    End date: 2011-03-24

Depakene
    Dosage: daily dose: 3000 mg
    Start date: 2011-02-21
    End date: 2011-03-27

Vimpat
    Start date: 2011-03-17
    End date: 2011-03-23

Vimpat
    Start date: 2011-03-24
    End date: 2011-03-28

Depakene
    Dosage: daily dose: 800 mg
    Start date: 2011-02-07
    End date: 2011-02-09

Depakene
    Dosage: daily dose: 1600 mg
    Start date: 2011-02-10
    End date: 2011-02-11

Depakene
    Dosage: daily dose: 1000 mg
    Start date: 2011-03-28
    End date: 2011-04-11

Lovenox
    Start date: 2011-02-07
    End date: 2011-02-21

Depakene
    Dosage: daily dose: 2000 mg
    Start date: 2011-02-12
    End date: 2011-02-20

Other drugs received by patient: Allopurinol; Colchicine; Celectol; Urbanyl; Irbesartan; Nexium



Possible Depakene side effects in 11 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-13

Patient: 11 year old female

Reactions: Activated Partial Thromboplastin Time Prolonged, Neutropenia, Coagulation Factor VII Level Decreased, Coagulation Factor V Level Decreased, Thrombocytopenia, Prothrombin Time Ratio Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-01-01
    End date: 2011-08-26

Lamotrigine
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-03-01
    End date: 2011-08-26

Artane
    Administration route: Oral
    Indication: Dystonia
    Start date: 2011-01-01
    End date: 2011-08-26

Other drugs received by patient: Zavesca



Possible Depakene side effects in 60 year old female

Reported by a physician from Belgium on 2011-10-10

Patient: 60 year old female

Reactions: Haemorrhage, Thrombocytopenia

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Temozolomide



Possible Depakene side effects in 81 year old male

Reported by a consumer/non-health professional from France on 2011-10-07

Patient: 81 year old male

Reactions: Hyponatraemia, Neutropenia, Drug Level Decreased, Thrombocytopenia, Convulsion, Anaemia Macrocytic, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diltiazem HCL
    Administration route: Oral

Dipyridamole
    Administration route: Oral

Tamsulosin HCL
    Administration route: Oral

Lasix
    Dosage: 40 mg daily
    Administration route: Oral

Prazosin HCL
    Administration route: Oral

Depakene
    Dosage: 500 mg, 2x/day
    Administration route: Oral
    Indication: Convulsion
    Start date: 1999-08-19
    End date: 2001-10-16

Other drugs received by patient: Celiprolol



Possible Depakene side effects in female

Reported by a physician from France on 2011-10-06

Patient: female

Reactions: Activated Partial Thromboplastin Time Prolonged, Factor VII Deficiency, Neutropenia, Thrombocytopenia, Factor V Deficiency, Prothrombin Level Decreased, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lamictal
    Dosage: 4mgkd per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-03-01
    End date: 2011-08-26

Artane
    Dosage: 16mg three times per day
    Administration route: Oral
    Indication: Dystonia
    Start date: 2011-01-01
    End date: 2011-08-26

Depakene
    Dosage: 31mgk per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-03-01
    End date: 2011-08-26

Other drugs received by patient: Miglustat



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-06

Patient: female

Reactions: Hypoproteinaemia, C-Reactive Protein Increased, Hypomagnesaemia, Hyponatraemia, Hypocalcaemia, Thrombocytopenia, Hypokalaemia

Drug(s) suspected as cause:
Akineton
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-07-08
    End date: 2009-07-13

Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2009-07-08

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tiapride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-06-08
    End date: 2009-06-23

Urbanyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-29
    End date: 2009-06-23

Risperdal
    Administration route: Oral
    Start date: 2009-04-23

Zolpidem
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2009-07-13

Akineton
    Administration route: Oral
    Start date: 2009-04-21
    End date: 2009-06-26

Risperdal
    Administration route: Oral
    End date: 2009-06-26

Other drugs received by patient: Levothyroxine Sodium



Possible Depakene side effects in 74 year old female

Reported by a pharmacist from France on 2011-10-04

Patient: 74 year old female

Reactions: Thrombocytopenia

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-21
    End date: 2009-07-08

Risperdal
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-23

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral
    End date: 2009-06-26

Akineton
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-21
    End date: 2009-06-26

Urbanyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-29
    End date: 2009-06-23

Zolpidem
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-21
    End date: 2009-07-13

Tiapride Panpharma
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-06-08
    End date: 2009-06-23

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017